HHS debuts H1N1 vaccine ad during football games
WASHINGTON The Department of Health and Human Services is continuing to advocate getting the H1N1 influenza vaccine, even this late into the season, as the agency announced last week the launch of a new H1N1 flu vaccination advertisement that aired during four college football bowl games held over the New Year’s holiday.
The ad is aimed at encouraging young people and all Americans to get vaccinated against the H1N1 flu.
“Young Americans have been especially hard hit by the 2009 H1N1 flu,” stated HHS secretary Sebelius. “Sports events are important opportunities to encourage fans, athletes, young adults and all Americans to protect themselves by getting the H1N1 vaccine. We hope that college athletic teams across the country will continue to join us in the fight against the H1N1 flu by getting vaccinated and encouraging others to get vaccinated too.”
With more than 110 million doses of the 2009 H1N1 vaccine now available, “all Americans are encouraged to get vaccinated and protect themselves and their loved ones during flu season, which typically lasts from October until May,” the agency stated.
For the week ended Dec. 26, rates of reported influenza-like illnesses continued to decline, though nationwide ILI incidence is still higher than is typical for this time of the year.
Tylenol Arthritis caplet recall becomes a bigger headache
NEW YORK Johnson & Johnson has expanded its voluntary recall of Tylenol Arthritis caplets in the wake of consumer reports of a moldy smell that can cause nausea and sickness. The recall now includes all product lots of the Arthritis Pain caplet 100-count bottles with the red EZ-Open cap.
Prior to this, the company had recalled five lots of the product in November, citing similar reasons, with user complaints of nausea, stomach pain, vomiting and diarrhea.
According to J&J, the odor is coming from trace amounts of 2,4,6-tribromoanisole — a chemical used to treat wooden pallets that transport and store packaging materials — which is believed to be the result from the breakdown of another chemical used in the manufacture of the drug.
To date, the side effects have been “temporary and non-serious,” although the health effects of the compound have not been studied.
The recall only affects the specific lots reported, and does not extend to any other Tylenol pain products.
J&J is moving its production of Tylenol Arthritis Pain caplets 100-count to another plant, and plans to reintroduce the product in January.
J&J is advising consumers seeking a refund or replacement to call (888) 222-6036.
P&G adds new products to Vicks DayQuil line
CINCINNATI Procter & Gamble on Wedneday introduced Vicks DayQuil Mucus Control and DayQuil Mucus Control DM. These products, which work for four hours, help loosen and thin mucus.
Vicks DayQuil Mucus Control provides mucus relief, making coughs more productive. In addition, DayQuil Mucus Control DM contains a cough suppressant for combined comfort of thinning mucus and controlling cough.
“When you are sick, your body produces excess mucus, which also becomes thicker and more difficult to clear,” stated Matt Kemme, brand manager, Vicks. “We’ve uncovered an insight that some consumers are restricting their mucus treatment to avoid coughing up phlegm in public,” he said. “The expectorant agent in Vicks DayQuil Mucus Control acts for four hours, helping people control over when and where they expel their mucus out.”
Average retail price ranges between $6.49 and $7.29.